The Problem of TP53-Mutant MDS/AML.

The Problem of TP53-Mutant MDS/AML. Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S65-S66 Authors: Sallman DA PMID: 32862873 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32862873?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - August 31, 2020 Category: Cancer & Oncology Authors: Sallman DA Tags: Clin Lymphoma Myeloma Leuk Source Type: research

More News: Cancer & Oncology | Lymphoma | Myeloma